Ilaria Gallelli

Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role

Simone Longhi, Candida Cristina Quarta, Agnese Milandri et al. · Amyloid · 2015 · 183 citations

Medicine, Cardiology, Clinical Cardiology +13

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom et al. · The Lancet · 2025 · 64 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy

Guido Rocchi, Matteo Bertini, M. Biffi et al. · European Heart Journal · 2008 · 56 citations · Full text

Medicine, Cardiology, Exercise Physiology +11

Short- and Long-Term Prognostic Significance of ST-Segment Elevation in Lead aVR in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

Nevio Taglieri, Antonío Marzocchi, Francesco Saia et al. · The American Journal of Cardiology · 2011 · 50 citations

Medicine, Cardiology, Internal Medicine +15

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17